SDC2 is involved in the tissue development and homeostasis, but its overexpression has also been described in various types of cancers, including breast cancer, favoring a more aggressive phenotype by the inhibition of apoptosis and promotion of cell migration, invasion, and metastasis34–37. Here, SDC2 is linked to cancer.